Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Eisaku, Morita, Satoshi, Nakamura, Atsushi, Hosomi, Yukio, Watanabe, Kana, Ikeda, Satoshi, Seike, Masahiro, Fujita, Yuka, Minato, Koichi, Ko, Ryo, Harada, Toshiyuki, Hagiwara, Koichi, Kobayashi, Kunihiko, Nukiwa, Toshihiro, Inoue, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622660/
https://www.ncbi.nlm.nih.gov/pubmed/35960896
http://dx.doi.org/10.1200/JCO.21.02911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622660/
https://www.ncbi.nlm.nih.gov/pubmed/35960896
http://dx.doi.org/10.1200/JCO.21.02911

Ejemplares similares